Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
Archives of Neurology
|
June 16, 2005
Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism
Michael A Hauser, Yi-Ju Li, Hong Xu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 2, 2022
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study
Aleksandra A Szwedo, Ingvild Dalen, Kenn Freddy Pedersen, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Single cell eQTL mapping reveals convergent glial-neuronal risk architecture in Parkinson's disease
Zechuan Lin, Jacob Parker, Vanitha Nithianandam, et al.
BMJ Open
|
February 26, 2022
Australian Parkinson's Genetics Study (APGS): pilot (n=1532)
Svetlana Bivol, George D Mellick, Jacob Gratten, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 7, 2021
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
Hirotaka Iwaki, Hampton L Leonard, Mary B Makarious, et al.
Journal of Parkinson'S Disease
|
December 13, 2021
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial
M Judith Peterschmitt, Hidemoto Saiki, Taku Hatano, et al.
Nature Neuroscience
|
November 29, 2018
Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Xianjun Dong, Zhixiang Liao, David Gritsch, et al.
Nature Neuroscience
|
September 19, 2018
Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Xianjun Dong, Zhixiang Liao, David Gritsch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 3, 2025
Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease
Yu Liao, Hao Wu, Junhao Wang, et al.
Neurology
|
January 29, 2026
Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias
Pia Kivisäkk, Hadia Fatima, Chao-Yi Wu, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
Archives of Neurology
|
June 16, 2005
Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism
Michael A Hauser, Yi-Ju Li, Hong Xu, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 2, 2022
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study
Aleksandra A Szwedo, Ingvild Dalen, Kenn Freddy Pedersen, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Single cell eQTL mapping reveals convergent glial-neuronal risk architecture in Parkinson's disease
Zechuan Lin, Jacob Parker, Vanitha Nithianandam, et al.
BMJ Open
|
February 26, 2022
Australian Parkinson's Genetics Study (APGS): pilot (n=1532)
Svetlana Bivol, George D Mellick, Jacob Gratten, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 7, 2021
Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
Hirotaka Iwaki, Hampton L Leonard, Mary B Makarious, et al.
Journal of Parkinson'S Disease
|
December 13, 2021
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial
M Judith Peterschmitt, Hidemoto Saiki, Taku Hatano, et al.
Nature Neuroscience
|
November 29, 2018
Publisher Correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Xianjun Dong, Zhixiang Liao, David Gritsch, et al.
Nature Neuroscience
|
September 19, 2018
Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Xianjun Dong, Zhixiang Liao, David Gritsch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 3, 2025
Genetic Analysis of the X Chromosome Associates Loci with Progression of Parkinson's Disease
Yu Liao, Hao Wu, Junhao Wang, et al.
Neurology
|
January 29, 2026
Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias
Pia Kivisäkk, Hadia Fatima, Chao-Yi Wu, et al.
Page
of 14